Antihypertensive drug is a kind of medicine that can control blood pressure and is used to treat hypertension.
This report contains market size and forecasts of Antihypertensive Drugs in global, including the following market information:
Global Antihypertensive Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antihypertensive Drugs Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Antihypertensive Drugs companies in 2021 (%)
The global Antihypertensive Drugs market was valued at 33720 million in 2021 and is projected to reach US$ 41920 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diuretic Antihypertensive Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antihypertensive Drugs include Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, Astra Zeneca and Daiichi Sankyo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antihypertensive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antihypertensive Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Antihypertensive Drugs Market Segment Percentages, by Type, 2021 (%)
Diuretic Antihypertensive
Sympathetic Suppressant
Renin-angiotensin System Inhibitor
Calcium Antagonist Medicine
vasodilator
Global Antihypertensive Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Antihypertensive Drugs Market Segment Percentages, by Application, 2021 (%)
The Old
Pregnant Woman
General Patient
Global Antihypertensive Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Antihypertensive Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antihypertensive Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antihypertensive Drugs revenues share in global market, 2021 (%)
Key companies Antihypertensive Drugs sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Antihypertensive Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics